Trastuzumab and ileus paralytic Patient Reports February 11, 2012

Trastuzumab Side Effects Report #5724013-2
Trastuzumab side effect was reported by a Physician from UNITED KINGDOM on Apr 17, 2008. Male patient, weighting 102.1 lb, was diagnosed with gastric cancer and was treated with Trastuzumab. After drug was administered, patient experienced the following side effects: disseminated intravascular coagulation, ileus paralytic, sepsis . Trastuzumab dosage: 278 MG, Q3W. During the same period patient was treated with CAPECITABINE, CISPLATIN, ZOLPIDEM TARTRATE, MAGNESIUM OXIDE, CALCIUM LACTATE, ALFACALCIDOL, VITAMIN B. Patient was hospitalized. Patient recovered.

Trastuzumab Side Effects Report #5779498-2
Trastuzumab side effect was reported by a Physician from UNITED KINGDOM on June 04, 2008. Male patient, weighting 102.1 lb, was diagnosed with gastric cancer and was treated with Trastuzumab. After drug was administered, patient experienced the following side effects: disseminated intravascular coagulation, ileus paralytic, sepsis , venous thrombosis. Trastuzumab dosage: 278 MG, Q3W. During the same period patient was treated with CAPECITABINE, CISPLATIN, ZOLPIDEM TARTRATE, MAGNESIUM OXIDE, CALCIUM LACTATE, ALFACALCIDOL, VITAMIN B. Patient was hospitalized. Patient recovered.

Trastuzumab Side Effects Report #5821958-X
Trastuzumab side effect was reported by a Physician from UNITED KINGDOM on July 11, 2008. Male patient, weighting 102.1 lb, was diagnosed with gastric cancer and was treated with Trastuzumab. After drug was administered, patient experienced the following side effects: disseminated intravascular coagulation, ileus paralytic, sepsis , venous thrombosis. Trastuzumab dosage: 278 MG, Q3W. During the same period patient was treated with CAPECITABINE, CISPLATIN, ZOLPIDEM TARTRATE, MAGNESIUM OXIDE, CALCIUM LACTATE, ALFACALCIDOL, VITAMIN B. Patient was hospitalized. Patient recovered.

Trastuzumab Side Effects Report #6092787-X
Trastuzumab side effect was reported by a Physician from UNITED KINGDOM on Feb 10, 2009. Male patient, weighting 102.1 lb, was diagnosed with gastric cancer and was treated with Trastuzumab. After drug was administered, patient experienced the following side effects: disseminated intravascular coagulation, ileus paralytic, sepsis , venous thrombosis. Trastuzumab dosage: 278 MG, Q3W. During the same period patient was treated with CAPECITABINE, CISPLATIN, ZOLPIDEM TARTRATE, MAGNESIUM OXIDE, CALCIUM LACTATE, ALFACALCIDOL, VITAMIN B. Patient was hospitalized. Patient recovered.


Trastuzumab Side Effects Report #5416617-1
Trastuzumab side effect was reported by a Physician from FRANCE on Aug 02, 2007. Female patient was diagnosed with breast cancer metastatic and was treated with Trastuzumab. After drug was administered, patient experienced the following side effects: abdominal pain , constipation , ileus paralytic. Trastuzumab dosage: 4 MG/KG, SINGLE. During the same period patient was treated with VINFLUNINE, LISINOPRIL, LITICAN, FORLAX. Patient was hospitalized. Patient recovered.

Trastuzumab Side Effects Report #5508161-8
Trastuzumab side effect was reported by a Physician from FRANCE on Oct 25, 2007. Female patient was diagnosed with breast cancer metastatic and was treated with Trastuzumab. After drug was administered, patient experienced the following side effects: abdominal pain , constipation , ileus paralytic. Trastuzumab dosage: 4 MG/KG, SINGLE. During the same period patient was treated with VINFLUNINE, LISINOPRIL, LITICAN, FORLAX. Patient was hospitalized. Patient recovered.